UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
______________
FORM 8-K
______________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of Earliest Event Reported):
April
27, 2017
USANA HEALTH
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Utah
(State
or other jurisdiction of incorporation)
001-35024 |
87-0500306 |
|
(Commission File No.) |
(IRS Employer Identification |
|
|
Number) |
3838 West Parkway Boulevard |
(Address of principal executive offices, Zip Code) |
Registrant’s telephone number, including area code: (801) 954-7100 |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 | Regulation FD Disclosure |
The Seeking Alpha web blog from yesterday was posted anonymously by a purported short seller based on the author’s opinion. The web blog contains multiple distortions of facts and misleading conclusions. USANA takes its global regulatory obligations seriously.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
USANA HEALTH SCIENCES, INC. |
|||
|
|||
|
|||
|
|
By: |
/s/ Paul A. Jones |
Paul A. Jones |
|||
Chief Financial Officer |
|||
|
|||
Date: |
April 28, 2017 |